Device Trial Radar · NCT05489588
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
Last checked: Nov 20, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
165
Planned (sponsor's estimate)
Start
Mar 2, 2023
Primary completion
Aug 2027
Study completion Mar 2031
Sponsor
- Lead sponsor
- W.L.Gore & AssociatesNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 5, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a prospective, non-randomized, multicenter, single-arm, clinical study to evaluate the performance, safety and efficacy of the GORE® VIABAHN® FORTEGRA Venous Stent (formerly known as GORE® VIAFORT Vascular Stent) for treatment of symptomatic iliofemoral venous obstruction.
Conditions
- Venous Thromboses
- Venous Disease
- Venous Leg Ulcer
- Venous Stasis
- Venous Ulcer
- Venous Stenosis
- Venous Occlusion
- Vein Thrombosis
- Vein Occlusion
- Vein Disease
Interventions
GORE® VIAFORT Vascular StentDevice
Treatment of unilateral symptomatic iliofemoral venous obstruction with the GORE® VIAFORT Vascular Stent.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite of safety eventsTime frame: 12 months (Stent Embolization) or 30 days (all other components)
- Primary efficacy as assessed by primary patencyTime frame: 12 months
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Stanford University School of Medicine
Stanford, California
Vascular Care Group
Darien, Connecticut
Yale University
New Haven, Connecticut
21 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.